TherapeuticsMD, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 02/14/2025 | 1.19 M | $1.03 M | 0.00% | 10.34% |
| CLEARLINE CAPITAL LP | 02/14/2025 | 635,222 | $546,291 | -0.22% | 5.51% |
| TEJARA CAPITAL LTD | 02/10/2025 | 394,661 | $339,408 | -1.69% | 3.42% |
| VANGUARD GROUP INC | 02/11/2025 | 387,582 | $333,321 | 0.00% | 3.36% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 270,160 | $232,338 | 0.00% | 2.34% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 116,132 | $99,874 | 0.00% | 1.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 108,333 | $93,203 | 0.00% | 0.94% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 34,000 | $29,243 | 0.00% | 0.29% |
| STATE STREET CORP | 02/14/2025 | 30,100 | $25,889 | 0.00% | 0.26% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 22,470 | $19,324 | 0.00% | 0.19% |
| J. GOLDMAN & CO LP | 02/14/2025 | 13,562 | $11,663 | 0.00% | 0.12% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 10,891 | $9,366 | 100.00% | 0.09% |
| FMR LLC | 02/13/2025 | 8,289 | $7,129 | 0.00% | 0.07% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 4,776 | $4,107 | 110.40% | 0.04% |
| UBS GROUP AG | 02/14/2025 | 2,012 | $1,730 | -58.49% | 0.02% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 1,135 | $976 | 100.00% | 0.01% |
| NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 610 | $525 | 0.00% | 0.01% |
| JPMORGAN CHASE & CO | 02/12/2025 | 315 | $271 | 7.51% | 0.00% |
| 02/06/2025 | 255 | $219 | 100.00% | 0.00% | |
| US BANCORP \DE\ | 02/05/2025 | 246 | $212 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 224 | $193 | 100.00% | 0.00% |
| HUNTINGTON NATIONAL BANK | 02/12/2025 | 120 | $103 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 97 | $83 | -32.64% | 0.00% |
| IFP ADVISORS, INC | 02/04/2025 | 80 | $69 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 01/28/2025 | 40 | $34 | 0.00% | 0.00% |
| 01/31/2025 | 40 | $34 | 100.00% | 0.00% | |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 30 | $49 | -46.43% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 02/10/2025 | 8 | $7 | 0.00% | 0.00% |
| ASSETMARK, INC | 02/06/2025 | 4 | $3 | 0.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 02/13/2025 | 3 | $3 | 100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/11/2025 | 2 | $2 | 100.00% | 0.00% |
| GUARDIAN WEALTH MANAGEMENT, INC. | 02/14/2025 | 2 | $2 | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/10/2025 | 1 | $1 | 0.00% | 0.00% |
| PRINCIPAL SECURITIES, INC. | 01/30/2025 | 0 | $0 | -100.00% | 0.00% |
| STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| ASPIRE PRIVATE CAPITAL, LLC | 01/17/2025 | 0 | $0 | -100.00% | 0.00% |
| CAPITAL PERFORMANCE ADVISORS LLP | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TherapeuticsMD, Inc. institutional Ownership - FAQ's
During the previous two years, 43 institutional investors and hedge funds held shares of TherapeuticsMD, Inc.. The most heavily invested institutionals were:
Rubric Capital Management LP: 1.19 M
Clearline Capital LP: 635,222
Tejara Capital Ltd: 394,661
VANGUARD GROUP INC: 387,582
ADAR1 Capital Management, LLC: 270,160
BlackRock Funding, Inc. /DE: 116,132
30.60% of TherapeuticsMD, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.56 M shares in the last 24 months. This purchase volume represents approximately $4.48 M in transactions.